What’s your story, why would I give you my money, and how will I get it back?

Sponsored by the WVU School of Pharmacy and the Office of Research and Graduate Education, a special, interactive session will offer expert insight on engaging potential biopharmaceutical research support. This session will be held on Thursday, Oct. 15, at noon in Room 2094, Health Sciences North, and is open to all faculty and students.

Edward Allera with Buchanan Ingersoll & Rooney PC, and Kevin Combs, founder, entrepreneur, and investor, will share their combined expertise on advising small company startups, interacting with large pharma, venture capital, and legal requirements facilitating FDA approval pathways. 

 

Edward Allera, Of Counsel, Buchanan Ingersoll & Rooney PC, advises clients on new product development and business opportunities in the areas of pharmaceuticals, hi-tech products, medical devices, food and cosmetics.  Mr. Allera has devoted his entire career to health care, as both a pharmacist (BS WVU SoP ’69) and an attorney (JD Georgetown ’74).  He began his career at the U.S. FDA where he served as associate chief counsel.  Because of his ability to integrate science and the law, he has become highly respected by clients in the pharma/biotech industry as the person to call in a “make-or-break” situation.  As an appointee to the board of the FDA’s Reagan-Udall Foundation, Ed joins a high-profile list of life sciences leaders including former FDA Commissioners, global biotech executives and CMS health policy administrators.  He has been selected by his peers for inclusion in The Best Lawyers in America® since 2021 in the area of FDA Law and was recognized as a leading Healthcare Pharmaceutical/Medical Products Regulatory lawyer in Washington, DC by Chambers USA since 2022.  Ed is the co-founder of the Value-Added Medicines Alliance, a not-for-profit association that assists emerging companies develop and market pharmaceuticals.  He is the Chairman of the Board of Integrated Pharmaceutical Solutions, a startup pharma company attempting to create pharma jobs in the US, and a member of the Country Roads Angel Network, a venture capital group that invests in entities whose goal is to create jobs in West Virginia.

Kevin Combs, founder, entrepreneur, investor with a successful track record of building and/or investing in companies that produce outsized value, while maintaining core values of integrity, passionate pursuit of purpose and consistent sustainability.  He has created over $2 billion in revenues and returns to investors and himself over the past 30yrs, by applying an internal set of algorithms guided by his education, life/work experiences and endless inputs from his incredibly diverse and talented network of friends and colleagues. He worked in large public pharma companies for 17 yrs in various commercial roles entry sales level to VP and all roles in between (GSK, MedImmune/AZ and Novartis.) Most recently he has helped to co-found Country Roads Angel Network and Country Roads Angel Foundation, a group focused on providing WV entrepreneurs and startups with missing pieces of the ecosystem, taken on the role of CEO at PS Fertility, sold his wound-care venture, Molecular Biologicals, Inc, co-founded a small SPV with 2 family offices to focus on early-stage life-science investments (Flourish Investments), became a partner in an artisanal beef processing company located in WV (Mountain Steer), co-founded a diagnostic and therapeutic treatment company that could have the 1st blood test to help diagnose and guide treatment of ALS patients (NK Immuno-T), and joined the board of a company developing a platform for genetic testing/optimal drug selection in lung cancers (Sostos). He is also on the board great young companies and organizations like: Merrand, Archemedx, Palvella (observer), Avil and Koru.